fbpx
  • Home
  • Study Details
Open

Eosinophilic gastritis and gastroenteritis Study

The purpose of this study is to learn more about a drug called Benralizumab and whether it can be used to safely treat eosinophilic Eosinophilic gastritis and gastroenteritis (EG/EGE).

Age & Gender

  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

At each visit you will have your vital signs taken, blood drawn, and urine collected. You will be asked to fill out questionnaires about your quality of life and symptoms and you will receive a drug injection (Benralizumab). You will have up to 4 endoscopies throughout the study.

Incentives

Information provided upon request, You will not be charged for the study drug, tests, and examinations that are a part of this study. Results of the trial will be available to you.

In-person visits:
8 - 24
Phone or online visits:
6
Total length of participation:
24 weeks, up to 2 years

Looking for Specific Volunteers

Able to participate:

  • eosinophilic gastritis or gastroenteritis (EG/EGE)

Not eligible if:

  • Other GI disorders such as Crohn's disease, inflammatory bowel disease, celiac disease, etc.
  • Are pregnant or plan on getting pregnant anytime within the next 2 years
  • active liver disease
  • a history of allerigic reactions to vaccines

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Visit Study Website

Primary Visit Location

Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Evan Dellon
Medicine-Gastroenterology

Study Type

Clinical or Medical
Interventional

Study Topics

Allergy
Chronic Conditions
Stomach, Digestion and Gut Health
Eating, Nutrition, and Metabolism
Rare Diseases

IRB Number

21-1642

ClinicalTrials.gov

TBD

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research